
Hybrid Neuroendocrine Cancers: Pathology, Grade Transformation, and Emerging Therapies
NETCast
00:00
Novel Targets and Oncolytic Virus Trial
Aman Chauhan highlights targets like TROP2 and the Seneca Valley virus trial leveraging TEM8 to sensitize NECs to immunotherapy.
Play episode from 27:43
Transcript


